NMI Holdings, Inc. files regulatory disclosures covering the parent company of National Mortgage Insurance Corporation and its private mortgage insurance business. Recent Form 8-K reports furnish results of operations and financial condition through earnings releases, while proxy materials address governance, executive compensation and pay-versus-performance disclosures. Other current reports document board expansion, independent-director appointments, committee service, director compensation arrangements, equity awards, indemnification agreements and stock ownership guidelines.
Insider sale and remaining holdings. Steven Scheid, a director of NMI Holdings, Inc. (NMIH), reported on Form 4 that he sold 19,926 common shares in open-market transactions on 09/15/2025 at a weighted average price of $39.3133 per share (trade range $39.1437 to $39.4601). After the reported sale, Mr. Scheid is shown as beneficially owning 78,960 shares indirectly through the Scheid Family Trust, of which he and his wife are co-trustees and beneficiaries. The filing also reports the disposition of 4,439 restricted stock units, noted as unvested. The Form 4 was signed by an attorney-in-fact on 09/17/2025. The document provides address details for the reporting person and confirms his status as a director.
Nicholas Daniel Realmuto, Vice President, Controller of NMI Holdings, Inc. (NMIH), reported two transactions in September 2025. On 09/13/2025 301 shares were withheld to satisfy taxes upon the vesting of restricted stock units originally granted on 09/13/2023, leaving 7,607 shares beneficially owned. On 09/16/2025 the reporting person sold 291 shares in an open market transaction at $38.52 per share, reducing beneficial ownership to 7,316 unvested restricted stock units. No derivative securities were reported.
NMI Holdings, Inc. (NMIH) filed a Form 144 notice reporting a proposed sale of 20,426 shares of common stock, with an aggregate market value of $805,397.00, representing part of the company's outstanding shares of 77,574,120. The sale is planned to occur on 09/15/2025 through Charles Schwab Corp. The shares were acquired as equity compensation in four grants dated 05/14/2021 (9,015 shares), 05/12/2023 (6,940 shares), 05/11/2024 (5,847 shares), and 05/09/2025 (4,166 shares). The filer reports no securities sold in the past three months and includes the standard representation that they are unaware of undisclosed material adverse information.